Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV
References (21)
- et al.
A time-to-prescription-refill measure of antiretroviral adherence predict ed changes in viral load in HIV
J Clin Epidemiol.
(2004) - et al.
Effect of adherence to newly initiated antiretroviral therapy on plasma viral load
AIDS
(2001) - et al.
Adherence to triple therapy and viral load response
J Acquir Immune Defic Syndr.
(2000) Adherence to HAART regimens
AIDS Patient Care STDS
(2003)- et al.
Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
Ann Intern Med.
(2000) - et al.
Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors
Clin Infect Dis.
(2005) - et al.
High levels of adherence do not prevent accumulation of HIV drug resistance mutations
AIDS
(2003) - et al.
Modeling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates
J Infect Dis.
(2004) - et al.
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
AIDS
(2000) - et al.
Marked intraindividual variability in antiretroviral concentrations may limit the utility of therapeutic drug monitoring
Clin Infect Dis.
(2006)
There are more references available in the full text version of this article.
Cited by (20)
Measurement issues in using pharmacy records to calculate adherence to antiretroviral drugs
2013, HIV Clinical TrialsMonitoring of Delay to Pharmacy Refill in Assessing Adherence to Antiretroviral Therapy
2020, Journal of Pharmacy PracticeSMS intervention on improving antiretroviral treatment adherence in HIV patients: A meta-analysis
2020, Chinese Journal of Evidence-Based Medicine
Copyright © 1997 Published by Elsevier Inc.